Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Embolization Agents Market: By Product, By Application, By End User and Region Forecast 2020-2031
Embolization Agents Market: By Product, By Application, By End User and Region Forecast 2020-2031
Embolization Agents Market size was valued at US$ 5.27 billion in 2024 and is expected to reach US$ 8.80 billion by 2031, growing at a significant CAGR of 7.6% from 2025-2031. Embolization agents are materials used in minimally invasive procedures to obstruct blood flow in targeted blood vessels for therapeutic purposes. These agents are crucial in treating various conditions, including tumors, aneurysms, and arteriovenous malformations. The increasing prevalence of cardiovascular diseases, cancer, and neurological disorders drives the market. Additionally, the growing preference for minimally invasive procedures contributes to market growth by reducing patient recovery time and complications.
Technological advancements in embolization materials, such as bioabsorbable beads and radiopaque agents, enhance treatment efficacy and expand the market. The aging global population, more susceptible to conditions requiring embolization, is expected to increase demand for these procedures. The market is also benefiting from increased healthcare expenditure and a growing focus on personalized medicine in many countries. However, challenges such as the high cost of advanced embolization agents and a shortage of interventional radiologists in some regions may hinder market growth. North America held the major market share and is expected to dominate the global market in the forecasted years.
In 2023, Terumo Corporation launched HydroPearl Microspheres with enhanced visibility, designed to:
Study Period
2025-2031Base Year
2024CAGR
7.9%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The increasing incidence of cancer, cardiovascular diseases, and neurological disorders is a significant driver for the embolization agents market. Embolization plays a crucial role in the treatment of these conditions, offering a minimally invasive alternative to traditional surgical approaches. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally. This high disease burden emphasizes the need for effective treatments, including embolization therapies. Furthermore, there has been a growing preference for minimally invasive procedures among both patients and healthcare providers. Embolization offers reduced recovery times, fewer complications, and improved quality of life compared to open surgery. The COVID-19 pandemic has also indirectly impacted the market by causing delays in non-emergency procedures, potentially leading to a backlog of cases requiring embolization treatments. However, the high cost of some advanced embolization agents and the need for specialized training to perform these procedures may hinder market growth in some regions.
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 5.27 billion |
|
Market Size in 2031 |
US$ 8.80 billion |
|
Market CAGR |
7.9% |
|
By Product |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Embolization agents market size was valued at US$ 5.27 billion in 2024 and is expected to reach US$ 8.80 billion by 2031, growing at a significant CAGR of 7.6% from 2025-2031.
The market is segmented based on Product, Application, End User, and Region.
The leading players in the market are Boston Scientific Corporation, Merit Medical Systems, Inc., Terumo Corporation, Sirtex Medical Limited, Johnson & Johnson, Medtronic plc, Cook Medical, Stryker Corporation, Penumbra, Inc., and Abbott Laboratories.
Asia-pacific is the fastest-growing region for market.
| 1.Executive Summary |
| 2.Global Embolization Agents Market Introduction |
| 2.1.Global Embolization Agents Market - Taxonomy |
| 2.2.Global Embolization Agents Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Embolization Agents Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Embolization Agents Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Embolization Agents Market By Product, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Coils |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Plugs |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Beads/Particles |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Detachable Balloons |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Glue |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Sponge |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Liquid Embolics |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Sclerosants |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Precipitating Agents |
| 5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6.Global Embolization Agents Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Oncology |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurology |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Urology |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Cardiology |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Peripheral Vascular Diseases |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Embolization Agents Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiac Centers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Embolization Agents Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Embolization Agents Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Coils |
| 9.1.2.Plugs |
| 9.1.3.Beads/Particles |
| 9.1.4.Detachable Balloons |
| 9.1.5.Glue |
| 9.1.6.Sponge |
| 9.1.7.Liquid Embolics |
| 9.1.8.Sclerosants |
| 9.1.9.Precipitating Agents |
| 9.1.10.Others |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology |
| 9.2.2.Neurology |
| 9.2.3.Urology |
| 9.2.4.Cardiology |
| 9.2.5.Peripheral Vascular Diseases |
| 9.2.6.Others |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Cardiac Centers |
| 9.3.3.Ambulatory Surgical Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Embolization Agents Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Coils |
| 10.1.2.Plugs |
| 10.1.3.Beads/Particles |
| 10.1.4.Detachable Balloons |
| 10.1.5.Glue |
| 10.1.6.Sponge |
| 10.1.7.Liquid Embolics |
| 10.1.8.Sclerosants |
| 10.1.9.Precipitating Agents |
| 10.1.10.Others |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology |
| 10.2.2.Neurology |
| 10.2.3.Urology |
| 10.2.4.Cardiology |
| 10.2.5.Peripheral Vascular Diseases |
| 10.2.6.Others |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Cardiac Centers |
| 10.3.3.Ambulatory Surgical Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Embolization Agents Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Coils |
| 11.1.2.Plugs |
| 11.1.3.Beads/Particles |
| 11.1.4.Detachable Balloons |
| 11.1.5.Glue |
| 11.1.6.Sponge |
| 11.1.7.Liquid Embolics |
| 11.1.8.Sclerosants |
| 11.1.9.Precipitating Agents |
| 11.1.10.Others |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology |
| 11.2.2.Neurology |
| 11.2.3.Urology |
| 11.2.4.Cardiology |
| 11.2.5.Peripheral Vascular Diseases |
| 11.2.6.Others |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Cardiac Centers |
| 11.3.3.Ambulatory Surgical Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Embolization Agents Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Coils |
| 12.1.2.Plugs |
| 12.1.3.Beads/Particles |
| 12.1.4.Detachable Balloons |
| 12.1.5.Glue |
| 12.1.6.Sponge |
| 12.1.7.Liquid Embolics |
| 12.1.8.Sclerosants |
| 12.1.9.Precipitating Agents |
| 12.1.10.Others |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology |
| 12.2.2.Neurology |
| 12.2.3.Urology |
| 12.2.4.Cardiology |
| 12.2.5.Peripheral Vascular Diseases |
| 12.2.6.Others |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Cardiac Centers |
| 12.3.3.Ambulatory Surgical Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Embolization Agents Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Coils |
| 13.1.2.Plugs |
| 13.1.3.Beads/Particles |
| 13.1.4.Detachable Balloons |
| 13.1.5.Glue |
| 13.1.6.Sponge |
| 13.1.7.Liquid Embolics |
| 13.1.8.Sclerosants |
| 13.1.9.Precipitating Agents |
| 13.1.10.Others |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology |
| 13.2.2.Neurology |
| 13.2.3.Urology |
| 13.2.4.Cardiology |
| 13.2.5.Peripheral Vascular Diseases |
| 13.2.6.Others |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Cardiac Centers |
| 13.3.3.Ambulatory Surgical Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Boston Scientific Corporation |
| 14.2.2.Merit Medical Systems, Inc. |
| 14.2.3.Terumo Corporation |
| 14.2.4.Sirtex Medical Limited |
| 14.2.5.Johnson & Johnson |
| 14.2.6.Medtronic plc |
| 14.2.7.Cook Medical |
| 14.2.8.Stryker Corporation |
| 14.2.9.Penumbra, Inc. |
| 14.2.10.Abbott Laboratories |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.